ND-L02-s0201 injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ND-L02-s0201 injection, covering 2017-05-11 to 2017-05-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects [Phase 1]